Mineralys Therapeutics
$26.41
7
-$0.68-2.51% Wednesday 20:00
Statistics
Day High
29.1
Day Low
26.27
52W High
47.65
52W Low
10.44
Volume
1,040,109
Avg. Volume
1,254,911
Mkt Cap
2.09B
P/E Ratio
-
Dividend Yield
-
Dividend
-
Upcoming
Earnings
18MayExpected
Expected EPS
-0.47585
Actual EPS
N/A
Financials
-Profit Margin
Unprofitable0Revenue
-355.62MNet Income
Analyst Ratings
$53.50Average Price Target
The highest estimate is 56.00.
From 4 ratings within the last 6 months. This is not an investment recommendation.
From 4 ratings within the last 6 months. This is not an investment recommendation.
Buy 100%
Hold 0%
Sell 0%
People Also Follow
This list is based on the watchlists of people on Stock Events who follow MLYS. It's not an investment recommendation.
Competitors
This list is an analysis based on recent market events. It's not an investment recommendation.
Ardelyx
ARDX
Mkt Cap1.47B
Aurinia Pharmaceuticals
AUPH
Mkt Cap1.73B
Trevena
TRVN
Mkt Cap10,365
Akebia Therapeutics
AKBA
Mkt Cap585.97M
Amarin
AMRN
Mkt Cap338.71M
Galmed Pharmaceuticals
GLMD
Mkt Cap7.51M
About
Mineralys Therapeutics, Inc., a clinical-stage biopharmaceutical company that develops therapies for the treatment of hypertension and associated cardiovascular diseases. It clinical-stage product candidate is lorundrostat, a proprietary, orally administered, highly selective aldosterone synthase inhibitor for the treatment of patients with uncontrolled or resistant hypertension. The company was incorporated in 2019 and is headquartered in Radnor, Pennsylvania.
Show more...
CEO
Mr. Jon Congleton
Employees
51
Country
US
ISIN
US6031701013
Listings
0 Comments
Share your thoughts
FAQ
What is Mineralys Therapeutics stock price today?▼
The current price of MLYS is $26.41 USD — it has decreased by -2.51% in the past 24 hours. Watch Mineralys Therapeutics stock price performance more closely on the chart.
What is Mineralys Therapeutics stock ticker?▼
Depending on the exchange, the stock ticker may vary. For instance, on exchange Mineralys Therapeutics stocks are traded under the ticker MLYS.
Is Mineralys Therapeutics stock price growing?▼
MLYS stock has risen by +11.86% compared to the previous week, the month change is a -9.92% fall, over the last year Mineralys Therapeutics has showed a +88.64% increase.
What is Mineralys Therapeutics market cap?▼
Today Mineralys Therapeutics has the market capitalization of 2.09B
When is the next Mineralys Therapeutics earnings date?▼
Mineralys Therapeutics is going to release the next earnings report on May 18, 2026.
What were Mineralys Therapeutics earnings last quarter?▼
MLYS earnings for the last quarter are -0.4 USD per share, whereas the estimation was -0.52 USD resulting in a +22.52% surprise. The estimated earnings for the next quarter are N/A USD per share.
What is Mineralys Therapeutics revenue for the last year?▼
Mineralys Therapeutics revenue for the last year amounts to 0 USD.
What is Mineralys Therapeutics net income for the last year?▼
MLYS net income for the last year is -355.62M USD.
How many employees does Mineralys Therapeutics have?▼
As of April 02, 2026, the company has 51 employees.
In which sector is Mineralys Therapeutics located?▼
Mineralys Therapeutics operates in the Health Care sector.
When did Mineralys Therapeutics complete a stock split?▼
Mineralys Therapeutics has not had any recent stock splits.
Where is Mineralys Therapeutics headquartered?▼
Mineralys Therapeutics is headquartered in Radnor, US.